Ampio Pharmaceuticals Reports Fourth-Quarter and Full-Year 2021 Financial Results and Operational Highlights

/PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the...

Related Keywords

United States ,Canada ,Englewood ,British Columbia ,American ,Michael Martino ,Howard Levy ,Nic Johnson ,Mike Martino ,Elizabeth Varki Jobes ,Holli Cherevka ,J Kevin Buchi ,Tony Russo ,Prnewswire Ampio Pharmaceuticals Inc ,Company Board Of Directors ,Million Expected To Fund Current Operations ,Exchange Commission ,Ampio Pharmaceuticals ,Ampio Pharmaceuticals Board Of Directors ,Paycheck Protection Program ,Ampio Pharmaceuticals Inc ,Clinical Development ,Cash Equivalents ,Fund Current Operations ,Conference Call Tuesday ,Ampion Biologics Licensing Application ,Per Protocol ,Typec Meeting ,Ampio Pharmaceuticals Board ,Chief Executive ,Chief Medical Officer ,Chief Operating ,Fourth Quarter ,Ended December ,Protection Program ,Toll Free ,Biologics Price Competition ,Innovation Act ,Private Securities Litigation Reform Act ,Annual Report ,Coronavirus Disease ,Media Contacts ,Nc ,Pharmaceuticals ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Earnings ,Clinical Trials Amp Medical Discoveries ,